EcoR1 Capital’s Eucrates Biomedical Acquisition Corp. Warrant EUCRW Stock Holding History

EcoR1 Capital’s Portfolio EUCRW Stock Details EUCRW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-66,666	Closed	-$676K	–	68
2023 Q1	$676K	Hold	66,666	–	–	0.02%	52
2022 Q4	$666K	Hold	66,666	–	–	0.02%	62
2022 Q3	$668K	Hold	66,666	–	–	0.02%	72
2022 Q2	$660K	Buy	+66,666	New	+$10.7K	0.02%	71
2022 Q1	–	Sell	-66,666	Closed	-$27K	–	99
2021 Q4	$651K	Hold	66,666	–	–	0.02%	71
2021 Q3	$652K	Hold	66,666	–	–	0.02%	66
2021 Q2	$656K	Hold	66,666	–	–	0.02%	67
2021 Q1	$665K	Buy	+66,666	New	+$108K	0.03%	66

EcoR1 Capital's EUCRW Position: Q2 2023 in Review

EcoR1 Capital sold out of Eucrates Biomedical Acquisition Corp. Warrant (EUCRW) in Q2 2023, closing a stake of 66,666 shares — an estimated $676K sold.

EcoR1 Capital first reported a position in EUCRW in Q1 2021 and held it in 8 quarters. The position peaked at $676K in Q1 2023. 0 funds tracked by Wall St. Rank hold EUCRW as of Q2 2023.

EcoR1 Capital reported no remaining Eucrates Biomedical Acquisition Corp. Warrant position as of Q2 2023 after selling out during the quarter.
EcoR1 Capital sold 66,666 Eucrates Biomedical Acquisition Corp. Warrant shares in Q2 2023, an estimated $676K.
EcoR1 Capital first reported a position in Eucrates Biomedical Acquisition Corp. Warrant in Q1 2021 and held it in 8 quarters.
EcoR1 Capital's Eucrates Biomedical Acquisition Corp. Warrant position peaked at $676K in Q1 2023.
0 funds tracked by Wall St. Rank held Eucrates Biomedical Acquisition Corp. Warrant as of Q2 2023.

Based on EcoR1 Capital's 13F filing for Q2 2023, filed 14 Aug 2023.